NeueHealth (NEUE) versus The Competition Financial Analysis

NeueHealth (NYSE:NEUE) is one of 14 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it compare to its rivals? We will compare NeueHealth to similar businesses based on the strength of its valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership.

Analyst Recommendations

This is a summary of current ratings and target prices for NeueHealth and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1125	2574	99	2.69

NeueHealth currently has a consensus target price of $8.00, suggesting a potential upside of 28.00%. As a group, “Hospital & medical service plans” companies have a potential upside of 16.47%. Given NeueHealth’s higher probable upside, research analysts clearly believe NeueHealth is more favorable than its rivals.

Risk & Volatility

NeueHealth has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, NeueHealth’s rivals have a beta of 0.95, indicating that their average stock price is 5% less volatile than the S&P 500.

Profitability

This table compares NeueHealth and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	-0.07%	-1.85%	0.08%

Valuation & Earnings

This table compares NeueHealth and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.80 billion	$2.78 billion	9.22

NeueHealth’s rivals have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

NeueHealth rivals beat NeueHealth on 10 of the 13 factors compared.

NeueHealth Company Profile

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.